3654 results for «401»
3654 results
A word from our sponsor
15 May 2023 – From PCR Innovators Day 2023
How will "Big Data" and artificial intelligence change the practice in Interventional Cardiology?
15 May 2023 – From PCR Innovators Day 2023
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
STEMI Vignettes - The global classroom
18 May 2023 – From EuroPCR 2023
Through these cases, explore global STEMI management and understand various geographic challenges and complication management approaches.
PCR's Got Talent - Round 1 - Session 2
16 May 2023 – From EuroPCR 2023
Did you participate in this session and want to enhance your memory? Take a look at the slides shared by the presenters and revisit the key points worth remembering.
Innovations in Heart Failure: Pumps, Remodeling and Monitoring
15 May 2023 – From PCR Innovators Day 2023
What else will become the "Next Big Thing" in Coronary Artery Disease, Peripheral Vascular, treatment of Hypertension or Cardiovascular Imaging for the Interventional Cardiologist?
15 May 2023 – From PCR Innovators Day 2023
Percutaneous thrombectomy of a large thrombus in transit
15 Jun 2022
View the case of a 60-year-old male patient who was diagnosed with pulmonary embolism and a large TIT, and see how he was treated by percutaneous thrombectomy.
Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials
14 Nov 2021
Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.
Author
Valve choice for TAVI: pros and cons for intra- and supra-annular prostheses
18 Jun 2026
In this expert review, Won-Keun Kim discusses key considerations for patient‑tailored transcatheter heart valve selection in index TAVI procedures, highlighting how valve type and design influence procedural success, long‑term outcomes, and lifetime management.
Author
IVUS-guided versus angiography-guided PCI in unprotected left main coronary artery disease – The OPTIMAL trial
31 Mar 2026
Ali Nazmi Calik provides his take on the results of the OPTIMAL trial presented by Luca Testa at ACC.26 in New Orleans.
Author
3-year Efficacy Outcomes From the Spyral Htn-on Med Pilot Study: Long Term Effect of Renal Denervation On Blood Pressure Reduction in Patients on Antihypertension Medications
22 Mar 2022
Ali Nazmi Calik provides his take on the long-term results of the SPYRAL HTN-ON MED trial which demonstrated the durable efficacy and safety of RDN in patients who are already on one to three antihypertensive drugs.
Author
OPTION-STEMI: Immediate versus staged complete revascularisation during index admission in patients with STEMI and multivessel disease
02 Sep 2025
Mirvat Alasnag provides her take on OPTION-STEMI, presented by Youngkeun Ahn at ESC Congress 2025 in Madrid.
Author
